Cited by 213Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismReceptor Mechanisms and Signaling

The concentration of synaptically released glutamate outside of the climbing fiber-Purkinje cell synaptic cleft

Open access
Dzubay, Jeffrey A., Jahr, Craig E.·1999·The Journal of Neuroscience

Abstract

AMPA receptors and glutamate transporters expressed by cerebellar Bergmann glial cells are activated by neurotransmitter released from climbing fibers (Bergles et al., 1997). Based on anatomical evidence, this is most likely the result of glutamate diffusing out of the climbing fiber–Purkinje cell synaptic clefts (Palay and Chan-Palay, 1974). We used the change in the EC 50 of the Bergmann glia AMPA receptors produced by cyclothiazide (CTZ) to estimate the concentration of glutamate reached at the glial membrane. The decrease of the EC 50 gives rise to a concentration-dependent potentiation of the AMPA receptor-mediated responses (Patneau et al., 1993). By comparing the increase in amplitude of the AMPA receptor response in the Bergmann glia (840 ± 240%; n = 8) with the shift in the glutamate dose–response curve measured in excised patches (EC 50 , 1810 μ m in control vs 304 μ m in CTZ), we estimate that the extrasynaptic transmitter concentration reaches 160–190 μ m . This contrasts with the concentration in the synaptic cleft, thought to rapidly rise above 1 m m , but is still high enough to activate glutamate receptors. These results indicate that the sphere of influence of synaptically released glutamate can extend beyond the synaptic cleft.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.19-13-05265.1999

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 50 μM and 1 mM glutamate approximately represent extrasynaptic and active synaptic glutamate levels, respectively.

    “Notably, 50 μM and 1 mM glutamate roughly estimate extrasynaptic and active synaptic glutamate levels, respectively”

    From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Dzubay & Jahr, 1999

    The Abstract (p. 5265) says glutamate in the synaptic cleft is thought to rapidly rise above 1 mM, supporting 1 mM as a rough synaptic value. But it estimates the extrasynaptic peak at 160–190 μM, not 50 μM. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Palay SL, Chan-Palay V (1974) The neuroglial cells of the cerebellar cortex and the climbing fiber. In: C erebellar cortex cytology and orga- nization (Palay SL, Chan-Palay V, eds), pp 288 -321. New York: Springer.

Cited by

Sorted by citations

Authors
Dzubay, J. A., & Jahr, C. E.
Affiliations
Oregon Health & Science University (US)
Venue
The Journal of Neuroscience
Published
1999-07-01
Volume
19
Issue
13
Pages
5265-5274
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2132949150
Cited by
213
References
1
Citations by year
2026: 6 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 14 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 7 · 2015: 10 · 2014: 6 · 2013: 3 · 2012: 8
FWCI
4.82
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1f31mh011978-01)
  • National Institute of Mental Health (MH11978)
  • National Institute of Neurological Disorders and Stroke (NS-21419, R01NS021419)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
extrasynaptic glutamate, Bergmann glia, AMPA receptors, glutamate transporters, cyclothiazide, glutamate diffusion, synaptic cleft, cerebellum, receptor potentiation
MeSH terms
Animals, Benzothiadiazines, Cell Membrane, Dose-Response Relationship, Drug, Kinetics, Models, Biological, Neuroglia, Probability, Purkinje Cells, Quinoxalines, Synapses, Temperature, Receptors, AMPA, Patch-Clamp Techniques, ATP-Binding Cassette Transporters, Glutamic Acid, Amino Acid Transport System X-AG, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review